Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 6, Pages 11402-11423
Publisher
MDPI AG
Online
2013-05-29
DOI
10.3390/ijms140611402
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Indium-111–labeled Girentuximab ImmunoSPECT as a Diagnostic Tool in Clear Cell Renal Cell Carcinoma
- (2013) Constantijn H.J. Muselaers et al. EUROPEAN UROLOGY
- Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
- (2013) Cor HJ Lamers et al. MOLECULAR THERAPY
- Phase 1 Radioimmunotherapy Study with Lutetium 177–labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma
- (2012) Alexander B. Stillebroer et al. EUROPEAN UROLOGY
- Positron Emission Tomography/Computed Tomography Identification of Clear Cell Renal Cell Carcinoma: Results From the REDECT Trial
- (2012) Chaitanya R. Divgi et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials
- (2011) Chris Coppin et al. BJU INTERNATIONAL
- Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX
- (2011) Margarita T. Murri-Plesko et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of Metastatic Disease
- (2011) Jean-Jacques Patard et al. EUROPEAN UROLOGY
- Dosimetric Analysis of 177Lu-cG250 Radioimmunotherapy in Renal Cell Carcinoma Patients: Correlation with Myelotoxicity and Pretherapeutic Absorbed Dose Predictions Based on 111In-cG250 Imaging
- (2011) A. B. Stillebroer et al. JOURNAL OF NUCLEAR MEDICINE
- Carbonic Anhydrase IX Expression in Renal Neoplasms
- (2010) Elizabeth M. Genega et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX-specific chimeric monoclonal antibody cG250
- (2010) Jeannette C. Oosterwijk-Wakka et al. BJU INTERNATIONAL
- Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
- (2010) Alexander B. Stillebroer et al. EUROPEAN UROLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
- (2010) M. Siebels et al. WORLD JOURNAL OF UROLOGY
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Incidental renal tumours
- (2009) Jean-Jacques Patard CURRENT OPINION IN UROLOGY
- PET/CT for the staging and follow-up of patients with malignancies
- (2009) T.D. Poeppel et al. EUROPEAN JOURNAL OF RADIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now